Viridian Therapeutics (NASDAQ:VRDN) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Viridian Therapeutics (VRDN) operate in?

Viridian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Viridian Therapeutics Stock (NASDAQ: VRDN) stock price, news, charts, stock research, profile.

Open	$19.85
Close	$19.62
Volume / Avg.	1.34M / 1.49M
Day Range	$19.46 - $20.41
52 Wk Range	11.40 - 27.20
Market Cap	$1.53B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	14.37%
Days to Cover	14.09

Recent News

Calavo Growers Posts Better-Than-Expected Earnings, Joins Tesla, Oracle, Mission Produce And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

Viridian Therapeutics Discloses 'Exciting' Data From Experimental Thyroid Eye Disease Candidate, Says Data Met High Bars For Efficacy, Safety

Viridian Therapeutics announced promising topline data from the THRIVE phase 3 trial of VRDN-001 (veligrotug) for active thyroid eye disease meeting all primary and secondary endpoints. Viridian plans to submit an FDA application for veligrotug in 2025.

Vandana Singh

Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$19.85
Close	$19.62
Volume / Avg.	1.34M / 1.49M
Day Range	$19.46 - $20.41
52 Wk Range	11.40 - 27.20
Market Cap	$1.53B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	14.37%
Days to Cover	14.09

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Viridian Therapeutics (VRDN) stock?

You can purchase shares of Viridian Therapeutics (NASDAQ:VRDN) through any online brokerage.

View our list of the best stock brokerages

Who are Viridian Therapeutics (VRDN) competitors?

Other companies in Viridian Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Syndax Pharmaceuticals (NASDAQ:SNDX), Day One Biopharmaceutical (NASDAQ:DAWN), Xencor (NASDAQ:XNCR) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).

What is the forecast, or price target, for Viridian Therapeutics (VRDN) stock?

Viridian Therapeutics has a consensus price target of $39.36.

What is the current price for Viridian Therapeutics (VRDN)?

The stock price for Viridian Therapeutics (NASDAQ: VRDN) is $19.3 last updated November 21, 2024 at 4:17 PM EST.

Does Viridian Therapeutics (VRDN) pay a dividend?

There are no upcoming dividends for Viridian Therapeutics.

When is Viridian Therapeutics (NASDAQ:VRDN) reporting earnings?

Viridian Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Is Viridian Therapeutics (VRDN) going to split?

There is no upcoming split for Viridian Therapeutics.

What sector and industry does Viridian Therapeutics (VRDN) operate in?

Viridian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Viridian Therapeutics

Viridian Therapeutics (VRDN) Forecast